Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza

Introduction. H2N2 influenza viruses caused a pandemic in 1957 due to the adaptation of avian influenza hemagglutinin from avian-type α2,3 to human-type α2,6 receptor specificity. These viruses have not circulated among humans for more than 50 years but are still found in avian reservoirs, indicatin...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria A. Matyushenko, Arina D. Kostromitina, Larisa G. Rudenko, Irina N. Isakova-Sivak
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2025-03-01
Series:Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.crie.ru/jour/article/viewFile/18803/1575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849708162560557056
author Victoria A. Matyushenko
Arina D. Kostromitina
Larisa G. Rudenko
Irina N. Isakova-Sivak
author_facet Victoria A. Matyushenko
Arina D. Kostromitina
Larisa G. Rudenko
Irina N. Isakova-Sivak
author_sort Victoria A. Matyushenko
collection DOAJ
description Introduction. H2N2 influenza viruses caused a pandemic in 1957 due to the adaptation of avian influenza hemagglutinin from avian-type α2,3 to human-type α2,6 receptor specificity. These viruses have not circulated among humans for more than 50 years but are still found in avian reservoirs, indicating their pandemic potential. It is known that at the beginning of a pandemic wave, viruses with α2,3 and α2,6 receptor specificities can co-circulate, and the selection of one or another isolate for the development of a better pandemic influenza vaccine should be based on strong scientific evidence. Although the vast majority of influenza vaccines are produced in chicken embryos, mammalian cell culture may be a preferred substrate for the production of pandemic influenza vaccines. Materials and methods. In this study, we investigated two variants of A/Singapore/1/57 (H2N2) virus which differed by their receptor specificity defined by three residues in the HA1 molecule: E156, Q226, G228 for α2,3 avian-type (Sing-α2,3) and K156, L226, S228 for α2,6 human-type (Sing-α2,6) receptor specificity. We conducted serial passaging of these viruses on MDCK cells and analyzed growth properties of plaque-purified clones in vitro and in vivo, as well as their immunogenicity and cross-reactivity in a mouse model. Results. Adaptation to MDCK cells significantly increased viral titers in MDCK cells; however, their receptor specificity was not affected. Viruses with α2,6 receptor specificity induced higher titers of homologous antibodies compared to the viruses with α2,3 receptor specificity, but these antibodies could react only with the α2,6 viruses. In contrast, antibody induced by viruses with α2,3 receptor specificity had broad reactivity against all studied viruses. Similar results were obtained for the pair of A/Leningrad/17-based H2N2 live attenuated influenza vaccines with α2,3 and α2,6 receptor specificities in experiments on Syrian hamsters. Conclusion. In the case of a new transmission of H2N2 avian influenza viruses to the human population and co-circulation of viruses with both receptor specificities, the variant with α2,3 specificity should be selected for the development of cross-reactive influenza vaccines.
format Article
id doaj-art-91ffa5ccc57d47ceb1bc6aec71c3ea19
institution DOAJ
issn 0372-9311
2686-7613
language Russian
publishDate 2025-03-01
publisher Central Research Institute for Epidemiology
record_format Article
series Журнал микробиологии, эпидемиологии и иммунобиологии
spelling doaj-art-91ffa5ccc57d47ceb1bc6aec71c3ea192025-08-20T03:15:44ZrusCentral Research Institute for EpidemiologyЖурнал микробиологии, эпидемиологии и иммунобиологии0372-93112686-76132025-03-011021314210.36233/0372-9311-6242812Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenzaVictoria A. Matyushenko0https://orcid.org/0000-0002-4698-6085Arina D. Kostromitina1https://orcid.org/0000-0001-5432-0171Larisa G. Rudenko2https://orcid.org/0000-0002-0107-9959Irina N. Isakova-Sivak3https://orcid.org/0000-0002-2801-1508Institute of Experimental MedicineInstitute of Experimental MedicineInstitute of Experimental MedicineInstitute of Experimental MedicineIntroduction. H2N2 influenza viruses caused a pandemic in 1957 due to the adaptation of avian influenza hemagglutinin from avian-type α2,3 to human-type α2,6 receptor specificity. These viruses have not circulated among humans for more than 50 years but are still found in avian reservoirs, indicating their pandemic potential. It is known that at the beginning of a pandemic wave, viruses with α2,3 and α2,6 receptor specificities can co-circulate, and the selection of one or another isolate for the development of a better pandemic influenza vaccine should be based on strong scientific evidence. Although the vast majority of influenza vaccines are produced in chicken embryos, mammalian cell culture may be a preferred substrate for the production of pandemic influenza vaccines. Materials and methods. In this study, we investigated two variants of A/Singapore/1/57 (H2N2) virus which differed by their receptor specificity defined by three residues in the HA1 molecule: E156, Q226, G228 for α2,3 avian-type (Sing-α2,3) and K156, L226, S228 for α2,6 human-type (Sing-α2,6) receptor specificity. We conducted serial passaging of these viruses on MDCK cells and analyzed growth properties of plaque-purified clones in vitro and in vivo, as well as their immunogenicity and cross-reactivity in a mouse model. Results. Adaptation to MDCK cells significantly increased viral titers in MDCK cells; however, their receptor specificity was not affected. Viruses with α2,6 receptor specificity induced higher titers of homologous antibodies compared to the viruses with α2,3 receptor specificity, but these antibodies could react only with the α2,6 viruses. In contrast, antibody induced by viruses with α2,3 receptor specificity had broad reactivity against all studied viruses. Similar results were obtained for the pair of A/Leningrad/17-based H2N2 live attenuated influenza vaccines with α2,3 and α2,6 receptor specificities in experiments on Syrian hamsters. Conclusion. In the case of a new transmission of H2N2 avian influenza viruses to the human population and co-circulation of viruses with both receptor specificities, the variant with α2,3 specificity should be selected for the development of cross-reactive influenza vaccines.https://microbiol.crie.ru/jour/article/viewFile/18803/1575influenza virush2n2receptor specificityadaptationmdck cellslive attenuated influenza vaccineimmunogenicity
spellingShingle Victoria A. Matyushenko
Arina D. Kostromitina
Larisa G. Rudenko
Irina N. Isakova-Sivak
Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
Журнал микробиологии, эпидемиологии и иммунобиологии
influenza virus
h2n2
receptor specificity
adaptation
mdck cells
live attenuated influenza vaccine
immunogenicity
title Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
title_full Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
title_fullStr Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
title_full_unstemmed Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
title_short Adaptation of H2N2 influenza viruses with different receptor specificity to MDCK cells: opportunities for the development of a cell-based vaccine against pandemic H2N2 influenza
title_sort adaptation of h2n2 influenza viruses with different receptor specificity to mdck cells opportunities for the development of a cell based vaccine against pandemic h2n2 influenza
topic influenza virus
h2n2
receptor specificity
adaptation
mdck cells
live attenuated influenza vaccine
immunogenicity
url https://microbiol.crie.ru/jour/article/viewFile/18803/1575
work_keys_str_mv AT victoriaamatyushenko adaptationofh2n2influenzaviruseswithdifferentreceptorspecificitytomdckcellsopportunitiesforthedevelopmentofacellbasedvaccineagainstpandemich2n2influenza
AT arinadkostromitina adaptationofh2n2influenzaviruseswithdifferentreceptorspecificitytomdckcellsopportunitiesforthedevelopmentofacellbasedvaccineagainstpandemich2n2influenza
AT larisagrudenko adaptationofh2n2influenzaviruseswithdifferentreceptorspecificitytomdckcellsopportunitiesforthedevelopmentofacellbasedvaccineagainstpandemich2n2influenza
AT irinanisakovasivak adaptationofh2n2influenzaviruseswithdifferentreceptorspecificitytomdckcellsopportunitiesforthedevelopmentofacellbasedvaccineagainstpandemich2n2influenza